InvestorsHub Logo

xoma4578

09/18/20 6:39 PM

#309006 RE: Dan88 #309004

So true Dan. Time will tell.

kabunushi

09/18/20 6:42 PM

#309007 RE: Dan88 #309004

They have a lot more to gain shorting at .90 than they would have being short at .17 or .35 that's for sure. OTOH I can imagine momentum buying at .35 or .55 or .65 and taking the profits here. Though I think there will be a much better selling op going into TLD if they want to bet against that. I'll be surprised if the stock is not above $1, maybe even 1.20-1.30 going into TLD, just on the technical action.

pqr

09/18/20 7:17 PM

#309022 RE: Dan88 #309004

Thank you Dan from me and other beginners.

sentiment_stocks

09/18/20 7:46 PM

#309036 RE: Dan88 #309004

it's actually very prevalent for hedge funds to have significant naked short positions in most small biotech companies in the face of a binary event



And I'd add that we've thought that we were facing a binary event for this stock since the summer of 2015. So finally now, we actually are.

marzan

09/18/20 10:10 PM

#309075 RE: Dan88 #309004

hmmmm Dan, no wonder no matter how good the trial results are AF can write a hit piece just picking on some random thing from the trial, and that's it these hedge funds short the heck of the stock using AF's article as cover. No wonder Learningcurve is telling us to wait until AF bring the share price back to 20c. Looks like this is their (AF Hedge fund combo) business model to make money no matter what. How do we protect our investment from these cons Dan? I think only LP can save us from these crooks. I wish she better announce the top line along with a partnership or b/o deal. See how AF brought down CYDY from $10 down to $4 throwing a fud article on their phase 2 results. How AF and MH brought down AMRN. Ruthless crooks. I bet AF and MH are compensated nicely.